The study analyzed the mechanisms behind NDURE, short for Navigation for Disparities and Untimely Radiation Therapy. The program was designed to coordinate the complex sequence of appointments, referrals and treatment decisions that follows major head and neck surgery. Unlike conventional navigation, which may respond to problems after they occur, NDURE anticipates the next clinical requirement and actively helps patients and care teams complete it before delays develop. In an earlier randomized clinical trial, nearly three-quarters of patients receiving enhanced navigation began radiation on time, compared with approximately 40 percent of those receiving standard navigation.

The new analysis, led by head and neck surgical oncologist Evan Graboyes, focused on why the intervention worked. Researchers divided the period between surgery and radiation into five measurable milestones. These included meeting a radiation oncologist before surgery, completing a dental evaluation before the operation, seeing a radiation oncologist within 21 days after surgery, undergoing radiation-planning scans promptly and beginning radiation within 14 days of those scans. Each step represents a potential point of failure in a care pathway that may involve multiple departments, hospitals and health systems.

Patients enrolled in the enhanced navigation program were significantly more likely to complete the milestones than those receiving usual care. The relationship between milestone completion and treatment timing was especially strong. Ninety percent of patients who completed four or five of the care steps began radiation within six weeks, compared with only 10 percent of patients who completed one or none. The pattern suggests that timely cancer care is not determined by a single appointment or physician decision, but by the successful coordination of a tightly connected clinical process.

One milestone had an especially large effect: the postoperative visit with a radiation oncologist within three weeks of surgery. This appointment accounted for nearly one-quarter of the overall benefit associated with the enhanced navigation program. On average, NDURE reduced the time to that visit by about five days. Investigators describe the appointment as a potential “gateway” in the treatment pathway because it brings the radiation oncology team into the patient’s care early enough to organize the remaining steps.

The technical importance of that timing is substantial. Radiation therapy requires treatment planning, which may include imaging, computer-based mapping of the surgical bed and surrounding tissues, dose calculations and decisions about how to protect healthy organs. Dental evaluation can also be essential because radiation involving the jaw and oral cavity may increase the risk of tissue injury or complications involving teeth and bone. If the radiation oncologist is not involved soon after surgery, these preparations may be compressed into the final days of the six-week window, leaving little room for scheduling problems, wound recovery, transportation barriers or communication failures.

Head and neck cancer care is particularly vulnerable to such breakdowns because it relies on a “team of teams.” Surgeons, radiation and medical oncologists, dentists, nurses, rehabilitation specialists and patient navigators must coordinate while the patient is recovering from a major operation. At MUSC Hollings, the challenge can be amplified when patients travel to Charleston for specialized surgery and then return to local communities for radiation. Information and responsibility may pass between institutions, making it harder to maintain a shared timeline.

The findings do not mean that every cancer center must adopt NDURE in its exact form. Instead, they offer practical performance targets that health systems can pursue through different methods, including electronic reminders, rapid referral pathways, dedicated scheduling staff, cross-institution communication protocols or patient navigation. The central lesson is that care coordination can be evaluated scientifically: researchers can track whether patients complete defined milestones and determine which steps contribute most to timely treatment. This approach moves cancer delivery research beyond the simple question of whether an intervention works and toward understanding its mechanism.

For patients, starting radiation within six weeks can affect the likelihood that treatment controls the disease and reduces the risk of recurrence. For health systems, the study provides a measurable roadmap for improving the transition from surgery to adjuvant therapy. The NDURE program is now being tested in a National Cancer Institute-funded multicenter trial involving MUSC, Baylor University, Duke University and Washington University in St. Louis. If the approach improves treatment timing across different hospitals and patient populations, it could offer a scalable model for closing one of the most persistent gaps in head and neck cancer care: ensuring that a medically recommended treatment is delivered not only correctly, but on schedule.

Subject of Research: People

Article Title: Mechanisms Underlying an Enhanced Navigation-Based Intervention to Improve Timely Adjuvant Therapy: A Secondary Analysis of the NDURE Randomized Clinical Trial

Web References: MUSC Hollings Cancer Center; JAMA Otolaryngology–Head & Neck Surgery; NDURE program; National Comprehensive Cancer Network guidelines

References: JAMA Otolaryngology–Head & Neck Surgery; MUSC Hollings Cancer Center; National Comprehensive Cancer Network

Image Credits: Clif Rhodes / Medical University of South Carolina

Keywords: Head and neck cancer, radiation therapy, cancer surgery, patient navigation, NDURE, health care delivery, treatment coordination, adjuvant therapy, oncology, cancer care timing

The award facilitates not only a deep dive into radiation oncology research but also clinical shadowing experiences that span key disciplines such as radiobiology, radiation physics, and therapeutic trials. Such integrative exposure aims to bolster students’ understanding of the complexities and innovations inherent in radiation-based cancer therapies.

Fayzullaev’s project scrutinizes whether patient educational content adheres to the American Medical Association’s guideline advocating for materials to be written at or below a sixth-grade reading level. This standard is critical to ensuring content accessibility and comprehension across diverse patient populations. His study evaluates printed and digital educational resources provided to breast, prostate, and lung cancer patients receiving radiation therapy at a Boston academic medical center.

To assess readability, Fayzullaev employs validated tools including the Flesch-Kincaid Grade Level and the Simple Measure of Gobbledygook (SMOG) index. These metrics quantify textual complexity by analyzing sentence length, syllabic density, and vocabulary difficulty. By correlating readability levels with patient adherence to radiation treatment protocols, the study aims to illuminate the role of communication clarity in clinical outcomes.

Fayzullaev emphasizes the pressing need for this research, citing the emotional and cognitive burden patients shoulder when confronted with intricate treatment regimens during vulnerable periods. Improved readability of discharge and after-visit summaries could significantly enhance patient understanding, fostering greater treatment compliance and potentially improving prognoses.

Originally from Uzbekistan, Fayzullaev’s academic journey reflects a dedication to integrating scientific inquiry with patient-centered care. His background includes hands-on research experience at Boston University’s analytical instrumentation core and its anatomy and neurobiology department. This foundation positions him well to contribute meaningfully to the evolving landscape of radiation oncology.

This fellowship not only highlights Fayzullaev’s promising scientific trajectory but also underscores the broader imperative of optimizing health communication. As cancer treatments grow increasingly sophisticated, ensuring patients can navigate their care effectively remains an essential component of therapeutic success.

Subject of Research: Readability of patient education materials in radiation oncology and its effect on treatment adherence at an urban safety net hospital
Article Title: Medical Student Awarded ASTRO Fellowship to Investigate Readability of Radiation Oncology Patient Materials
News Publication Date: (Boston)—[Exact date not provided]
Keywords: Radiation Oncology, Patient Education, Readability, Treatment Adherence, Medical Student Fellowship, Flesch-Kincaid, SMOG, Health Communication

The ACS’s study involves an extensive dataset from over 90,000 cancer patients across multiple institutions accredited by the ACS Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC). The two-year collaborative program, known as Breaking Barriers, was designed to identify, understand, and reduce the multiple factors contributing to poor radiation therapy adherence. This initiative is among the largest efforts worldwide to systematically address appointment non-compliance in cancer therapy through structured interventions at the hospital and patient levels.

Cancer therapy adherence is a complex, multifactorial issue affected by an interplay of socioeconomic, psychological, and systemic barriers. Breaking Barriers pinpointed four primary obstacles influencing patients’ abilities to maintain their radiation schedules: transportation difficulties, non-cancer-related illnesses, scheduling conflicts with other medical or personal appointments, and patients’ own decisions to discontinue treatment. Among these, transportation issues emerged as the predominant barrier, afflicting up to 62% of patients with missed appointments. This reflects systemic gaps in healthcare access infrastructure, particularly in regions lacking affordable public transit or where patients live at considerable distances from treatment centers.

Illnesses unrelated to cancer treatment, including mental health conditions such as depression and anxiety, accounted for a significant proportion of missed sessions, highlighting the importance of holistic patient care. Treatment adherence is not solely a physical challenge but often a psychological and emotional struggle for patients navigating a demanding therapeutic regimen. Additionally, competing appointments and sometimes patients’ reluctance to continue treatment underscore the necessity for personalized patient engagement and support systems.

An essential insight from the study was the realization that no universal solution effectively addresses all patient populations. The diversity of regional, socio-economic, and cancer-type-specific challenges demands tailored approaches. For instance, while the South and Midwest regions showed considerable improvements after interventions, the Northeast demonstrated less pronounced gains, potentially due to distinct local barriers. Similarly, certain cancer types such as gynecologic, gastrointestinal, and breast cancers displayed more substantial reductions in missed appointments, while prostate and lung cancers lagged, indicating differences in patient population dynamics and treatment regimens.

The Breaking Barriers program encouraged participating hospitals to apply a multifaceted strategy, on average implementing four distinct interventions to tackle the identified obstacles. Key measures included the enhancement of electronic health record systems to automate timely appointment reminders, refinement of clinical workflows to assist patients in securing affordable and reliable transportation, and the employment of patient navigators who proactively followed up with individuals at risk of missing appointments. These interventions collectively contributed to nearly a 40% reduction in missed radiation therapy appointments at the patient level and a 32% median reduction at the hospital level.

While the study reflects progress, it also underscores ongoing disparities, particularly within community hospitals, which often serve smaller patient populations and reported higher baseline no-show rates. These institutions only saw modest improvements, indicating that more bespoke support frameworks and resource allocation may be necessary to effectively combat barriers unique to these settings. The recognition of such institutional variances is crucial to improving equity in cancer care nationwide.

This extensive endeavor also illuminates the critical role of integrating patient-reported data into quality improvement programs. By directly involving patients in articulating the barriers they face, healthcare providers can develop interventions that target real-world challenges rather than relying solely on clinical assumptions. Moreover, the program’s longitudinal design allowed for monitoring changes over time and assessing the sustainability of interventions, offering a valuable model for future efforts aiming to enhance treatment adherence across various domains of oncology and beyond.

Importantly, the Breaking Barriers initiative not only addressed logistical and clinical aspects but also acknowledged the psychological dimensions influencing patient compliance. Depression, anxiety, and the emotional toll of cancer treatment demand integrated care models that encompass mental health support alongside physical therapy. The authors advocate for the expansion of such holistic frameworks to encompass other critical treatment modalities, including chemotherapy adherence, with the potential for substantial impact on overall cancer survival rates.

The study’s methodological rigor, involving prospective data collection and robust statistical analysis across a broad cohort of patients, strengthens its findings. Nonetheless, the authors note limitations, particularly the potential underreporting or oversimplification of the nuanced challenges patients experience. Future research is warranted to refine data capture methodologies and explore region-specific cultural, economic, and health system factors that influence treatment continuity.

In summary, Breaking Barriers is a pioneering effort demonstrating that structured, evidence-based quality improvement strategies can markedly reduce missed radiation therapy appointments among cancer patients. By addressing transportation, illness, scheduling conflicts, and patient motivation through targeted interventions, healthcare systems can improve treatment completion rates, thereby enhancing patient outcomes. This initiative sets a precedent for collaborative, patient-centered approaches to overcoming treatment adherence challenges in oncology and may catalyze similar programs globally.

The implications of this research extend beyond radiation therapy, suggesting a paradigm shift in how healthcare systems identify and tackle barriers to care. It underscores a multi-stakeholder responsibility that involves clinicians, administrators, policy makers, and patients themselves. With the healthcare landscape continuously evolving, such innovative quality improvement collaboratives serve as invaluable models for elevating cancer care standards and optimizing survival in this vulnerable population.

Subject of Research: People

Article Title: Results of an American College of Surgeons Prospective National Quality Improvement Collaborative to Successfully Overcome Barriers to Cancer Care Across the US

News Publication Date: 11-Nov-2025

Web References:

• Journal of the American College of Surgeons article
• American College of Surgeons Breaking Barriers program

References:
Chan K, Reilly E, Janczewski LM. Results of an American College of Surgeons Prospective National Quality Improvement Collaborative to Successfully Overcome Barriers to Cancer Care Across the US. Journal of the American College of Surgeons, 2025. DOI: 10.1097/XCS.0000000000001637

Keywords: Cancer treatments, Radiation therapy